Arrayit Debt to Equity Ratio 2010-2015 | ARYC

Current and historical debt to equity ratio values for Arrayit (ARYC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Arrayit debt/equity for the three months ending September 30, 2015 was 0.00.
Arrayit Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2015-09-30 $0.01B $-0.01B -1.15
2015-06-30 $0.01B $-0.01B -1.15
2015-03-31 $0.01B $-0.01B -1.14
2014-12-31 $0.01B $-0.01B -1.15
2014-09-30 $0.01B $-0.01B -1.18
2014-06-30 $0.01B $-0.01B -1.22
2014-03-31 $0.01B $-0.01B -1.31
2013-12-31 $0.01B $-0.01B -1.27
2013-09-30 $0.01B $-0.01B -1.12
2013-06-30 $0.01B $-0.01B -1.08
2013-03-31 $0.01B $-0.01B -1.06
2012-12-31 $0.01B $-0.01B -1.07
2012-09-30 $0.01B $-0.01B -1.07
2012-06-30 $0.01B $-0.01B -1.06
2012-03-31 $0.01B $-0.01B -1.04
2011-12-31 $0.01B $-0.01B -1.06
2011-09-30 $0.01B $-0.01B -1.06
2011-06-30 $0.01B $-0.01B -1.06
2011-03-31 $0.01B $-0.01B -1.07
2010-12-31 $0.01B $-0.01B -1.07
2010-09-30 $0.01B $-0.01B -1.05
2010-06-30 $0.01B $-0.01B -1.06
2010-03-31 $0.01B $-0.01B -1.08
2009-12-31 $0.01B $-0.01B -1.08
2009-09-30 $0.00B 0.00
2009-06-30 $0.01B $-0.01B -1.08
2009-03-31 $0.03B $-0.03B -1.03
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.000B $0.000B
Arrayit Corporation leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. Headquartered in Sunnyvale, California, the company provides products and services to scientists and clinicians to explore the human genome, as well as the genomes of plants and animals. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. The Company's product portfolio includes microarrayers, microarray scanners, microarray printing, substrates and slides, amplification and labeling, purification kits, microarray hardware, buffers and solutions, microarray cleanrooms, books and software, comparative genomic hybridization microarrays and microarray platforms.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.485B 26.47
Intuitive Surgical (ISRG) United States $135.271B 81.49
Edwards Lifesciences (EW) United States $51.372B 33.43
DexCom (DXCM) United States $51.051B 77.33
IQVIA Holdings (IQV) United States $40.542B 23.61
IDEXX Laboratories (IDXX) United States $39.691B 46.52
Alcon (ALC) Switzerland $39.236B 28.93
STERIS (STE) Ireland $20.536B 24.31
Waters (WAT) United States $19.053B 27.34
Hologic (HOLX) United States $17.966B 19.98
SONOVA HOLDING (SONVY) Switzerland $17.387B 0.00
ShockWave Medical (SWAV) United States $12.392B 85.37
Fresenius Medical Care AG KGaA (FMS) Germany $12.306B 15.20
Sysmex ADR (SSMXY) Japan $10.920B 34.24
Teleflex (TFX) United States $9.562B 14.88
Penumbra (PEN) United States $8.083B 99.78
Masimo (MASI) United States $7.249B 40.65
Globus Medical (GMED) United States $7.033B 22.30
Glaukos (GKOS) United States $5.346B 0.00
TransMedics (TMDX) United States $4.187B 399.97
Integer Holdings (ITGR) United States $3.728B 22.52
LivaNova (LIVN) United Kingdom $3.474B 20.63
PROCEPT BioRobotics (PRCT) United States $3.306B 0.00
Tandem Diabetes Care (TNDM) United States $2.887B 0.00
Elekta AB (EKTAY) Sweden $2.712B 18.61
Nihon Kohden (NHNKY) Japan $2.490B 21.06
Inari Medical (NARI) United States $2.444B 0.00
RxSight (RXST) United States $2.281B 0.00
Integra LifeSciences Holdings (IART) United States $2.271B 9.32
Alphatec Holdings (ATEC) United States $1.908B 0.00
Veracyte (VCYT) United States $1.556B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.909B 17.57
OPKO Health (OPK) United States $0.906B 0.00
Paragon 28 (FNA) United States $0.873B 0.00
Artivion (AORT) United States $0.862B 99.67
Silk Road Medical (SILK) United States $0.800B 0.00
OrthoPediatrics (KIDS) United States $0.781B 0.00
Treace Medical Concepts (TMCI) United States $0.679B 0.00
Mesa Laboratories (MLAB) United States $0.623B 21.15
SiBone (SIBN) United States $0.585B 0.00
IRadimed (IRMD) United States $0.566B 31.70
ORTHOFIX MEDICAL INC (OFIX) United States $0.509B 0.00
Pacific Biosciences Of California (PACB) United States $0.498B 0.00
Pulse Biosciences (PLSE) United States $0.432B 0.00
Nevro (NVRO) United States $0.414B 0.00
NeuroPace (NPCE) United States $0.392B 0.00
Tactile Systems Technology (TCMD) United States $0.339B 11.42
Sight Sciences (SGHT) United States $0.295B 0.00
EDAP TMS S.A (EDAP) France $0.265B 0.00
AxoGen (AXGN) United States $0.253B 0.00
AngioDynamics (ANGO) United States $0.251B 0.00
Atossa Genetics (ATOS) United States $0.208B 0.00
CVRx (CVRX) United States $0.199B 0.00
Semler Scientific (SMLR) United States $0.190B 10.23
908 Devices (MASS) United States $0.186B 0.00
Alpha Tau Medical (DRTS) Israel $0.173B 0.00
Inogen (INGN) United States $0.168B 0.00
Accuray (ARAY) United States $0.161B 0.00
ClearPoint Neuro (CLPT) United States $0.159B 0.00
Delcath Systems (DCTH) United States $0.154B 0.00
Neuronetics (STIM) United States $0.114B 0.00
KORU Medical Systems (KRMD) United States $0.106B 0.00
Spectral Diagnostics (EDTXF) Canada $0.095B 0.00
Envoy Medical (COCH) United States $0.085B 0.00
Yubo Biotech (YBGJ) China $0.070B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
Monogram Orthopaedics (MGRM) United States $0.061B 0.00
Sensus Healthcare (SRTS) United States $0.060B 121.67
SEP Acquisition (SEPA) United States $0.059B 0.00
Autonomix Medical (AMIX) United States $0.058B 0.00
Hyperfine (HYPR) United States $0.058B 0.00
Vicarious Surgical (RBOT) United States $0.055B 0.00
InspireMD (NSPR) Israel $0.047B 0.00
DarioHealth (DRIO) United States $0.047B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
ReWalk Robotics (LFWD) Israel $0.041B 0.00
Aspira Women's Health (AWH) United States $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.038B 0.00
LENSAR (LNSR) United States $0.037B 0.00
Pixie Dust Technologies (PXDT) Japan $0.037B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.026B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
T2 Biosystems (TTOO) United States $0.021B 0.00
Accelerate Diagnostics (AXDX) United States $0.020B 0.00
PAVmed (PAVM) United States $0.020B 0.00
Biosig Technologies (BSGM) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00